BioSpace News Archive

Rheos Medicines, a precision medicine company using insights from immunometabolism to bring novel therapeutics to patients suffering from autoimmune diseases, and PatientsLikeMe, the world’s largest integrated community, health management, and real-world data platform, today announced a strategic partnership.

Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, today announced the Company will be added to the Russell 2000® and Russell

Biotech startup has developed a new genetic coding process to synthesize proteins and peptide hormones; rBIO’s platform for synthetic insulin achieves success as the team looks to production scale-up and a range of other prescription drugs to target

Stemina’s Human Cell-Based devTOX quick Predict Assay Able to Predict Developmental Toxicity Potential of Nicotine-Containing Products New research study published in the scientific journal Current Research in Toxicology

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced the company will present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021, at 2:00 p.m. ET/11:00 a.m. PT.

IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Glenn P. Sblendorio, Chief Executive Officer and President, will present an overview of the Company at the 39th Annual J.P. Morgan Healthcare Conference in a virtual session on Thursday, January 14, 2021 at 2:50 p.m. Eastern Time.

RTC Utilizes AT&T IoT Video Intelligence Solution with Hitachi Vantara Technology to Deliver Body Temperature Thermal Imaging Analysis

Essence Group , a leading global IoT solutions provider, today announced it will showcase two advanced 5G-connected IoT devices at the upcoming CES that demonstrate the company’s position at th

Kubota Vision Inc., a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd., announced that the company achieved a milestone by completing a first spectacle-style wearable prototype based on Kubota Glasses technology.

Regulatory News Transgene (Paris:TNG) today announced its financial reporting dates for 2021: March 10, 2021: 2020 Fiscal Year Results April 27, 2021: First Quarter 2021 Financial Results May 26, 2021: Annual Shareholders’ Meeting